Roquette Company Profile

Background

Overview

Roquette is a family-owned global leader in plant-based ingredients and a leading provider of pharmaceutical excipients. Founded in 1933 by brothers Dominique and Germain Roquette in Lestrem, France, the company has grown to operate in over 100 countries, with more than 40 manufacturing sites and 20 research and development centers. In 2024, Roquette reported a turnover of €4.5 billion.

Mission and Vision

Roquette's mission is to unlock the potential of nature to improve, cure, and save lives by offering the best of nature in collaboration with its customers and partners. The company is committed to enhancing the quality and convenience of essential products for consumers and patients worldwide.

Primary Area of Focus

Roquette specializes in producing plant-based ingredients and pharmaceutical excipients derived from natural resources such as wheat, corn, potatoes, and peas. These products are utilized in various sectors, including food, nutrition, health, and bioindustry.

Industry Significance

As a global leader in plant-based ingredients, Roquette plays a pivotal role in the food, nutrition, and pharmaceutical industries. Its innovative solutions address societal challenges by providing sustainable and health-oriented products, thereby contributing to the advancement of these sectors.

Key Strategic Focus

Core Objectives

• Sustainability: Roquette places sustainable development at the heart of its operations, focusing on sustainable sourcing, improving operational efficiency, and developing innovations that address consumer needs.

• Innovation: The company is committed to continuous innovation, aiming to offer high-performance ingredients and solutions that enhance the quality and convenience of essential products.

Specific Areas of Specialization

• Plant-Based Ingredients: Roquette specializes in producing plant-based ingredients such as starches, polyols, proteins, and fibers, catering to various applications in the food, nutrition, and health sectors.

• Pharmaceutical Excipients: The company provides pharmaceutical excipients that play a key role in medical treatments, ensuring the quality and efficacy of pharmaceutical products.

Key Technologies Utilized

• Biorefining: Roquette employs biorefining technologies to process plant-based raw materials into a wide range of products, enhancing the value derived from natural resources.

• Sustainable Practices: The company integrates sustainable practices across its operations, from sourcing raw materials to product development, aligning with its commitment to environmental responsibility.

Primary Markets Targeted

• Food and Nutrition: Roquette serves the food and nutrition markets by providing ingredients that meet functional, nutritional, and textural needs in food manufacturing.

• Pharmaceuticals: The company supplies pharmaceutical excipients that are essential in the formulation of oral medications and advanced biopharmaceuticals.

Financials and Funding

Funding History

Roquette is a privately held, family-owned company and does not publicly disclose detailed funding histories. However, it has made significant investments in acquisitions to strengthen its position in the pharmaceutical sector.

Recent Funding Rounds

• Acquisition of IFF Pharma Solutions: In March 2024, Roquette announced the acquisition of the pharmaceutical solutions business from International Flavors & Fragrances (IFF) for $2.85 billion. This strategic move aims to enhance Roquette's capabilities in the pharmaceutical sector.

Notable Investors

As a family-owned company, Roquette's investments and funding are primarily managed by the Roquette family, with no external investors publicly disclosed.

Utilization of Capital

The capital from recent acquisitions is intended to expand Roquette's presence in the pharmaceutical market, particularly in the area of pharmaceutical excipients, thereby diversifying its product portfolio and enhancing its market position.

Pipeline Development

Key Pipeline Candidates

Roquette's pipeline includes a range of plant-based ingredients and pharmaceutical excipients designed to meet the evolving needs of the food, nutrition, and pharmaceutical industries. Specific details about individual pipeline candidates are not publicly disclosed.

Stages of Development

Roquette's products undergo rigorous research and development processes, including laboratory testing, pilot-scale production, and commercial-scale manufacturing, to ensure quality and efficacy.

Target Conditions

The company's pharmaceutical excipients are developed to support various medical treatments, ensuring the stability and bioavailability of active pharmaceutical ingredients.

Anticipated Milestones

Roquette continues to innovate and expand its product offerings, with anticipated milestones in the development of new plant-based ingredients and pharmaceutical excipients to meet market demands.

Technological Platform and Innovation

Proprietary Technologies

• Biorefining Processes: Roquette utilizes proprietary biorefining processes to convert plant-based raw materials into a diverse range of high-value products, enhancing the sustainability and efficiency of its operations.

Significant Scientific Methods

• Sustainable Sourcing: The company employs sustainable sourcing methods to ensure the responsible procurement of raw materials, aligning with its commitment to environmental stewardship.

• Product Development: Roquette's product development involves advanced scientific methodologies, including the use of plant-based proteins and fibers, to create innovative solutions for the food, nutrition, and pharmaceutical markets.

Leadership Team

Executive Profiles

• Thierry Fournier: Chief Executive Officer (CEO) since July 18, 2025. Thierry brings a distinguished international background in engineering and a passion for materials and sciences, guiding Roquette into its next chapter.

• Isabelle Bouvier: CEO of the Health & Pharma Business Group, leading Roquette's initiatives in the pharmaceutical sector.

• Pascal Leroy: CEO of the Nutrition & Bioindustry Business Group, overseeing Roquette's operations in the nutrition and bioindustry sectors.

• Béatrice Totel: Chief Financial Officer (CFO), responsible for managing Roquette's financial operations.

• Marc Peeters: Chief Human Resources Officer, overseeing human resources strategies and initiatives.

• Xavier Galliot: Chief Sustainability & Stakeholder Engagement Officer, leading sustainability efforts and stakeholder relations.

• Delphine Desrumaux: General Counsel, providing legal guidance and support.

• Guillaume Fichet: Chief Operating Officer, responsible for overseeing Roquette's global operations.

• Michael Manouvrier: Chief Digital and Information Officer, leading digital transformation and information technology strategies.

Competitor Profile

Market Insights and Dynamics

The global market for plant-based ingredients and pharmaceutical excipients is experiencing significant growth, driven by increasing consumer demand for sustainable and health-oriented products. Roquette's extensive global presence and diverse product portfolio position it well to capitalize on these market trends.

Competitor Analysis

• Cargill: A major player in the plant-based ingredients market, offering a wide range of products across various sectors.

• ADM (Archer Daniels Midland): A global leader in agricultural processing, providing plant-based ingredients and solutions.

• Ingredion: Specializes in plant-based ingredients and pharmaceutical excipients, serving multiple industries.

Strategic Collaborations and Partnerships

Roquette has engaged in strategic collaborations to enhance its market position:

• Acquisition of Qualicaps: In October 2023, Roquette acquired Qualicaps, a Japanese drug capsule maker, expanding its presence in the pharmaceutical sector.

• Acquisition of IFF Pharma Solutions: In May 2025, Roquette completed the acquisition of IFF Pharma Solutions, a division of International Flavors & Fragrances, for $2.85 billion, strengthening its capabilities in pharmaceutical excipients.